Collecting blood samples from patients with low platelet counts due to blood cancers
Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia
This study is collecting blood samples from adults with low platelet counts caused by blood cancers to see how it affects their treatment and recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 88 Years |
| Sex | All |
| Sponsor | Case Comprehensive Cancer Center Academic / other |
| Drugs / interventions | Chemotherapy, radiation |
| Locations | 1 site (Cleveland, Ohio) |
| Trial ID | NCT06824727 on ClinicalTrials.gov |
What this trial studies
This research project aims to collect blood samples from adults suffering from thrombocytopenia, a condition characterized by low platelet counts, particularly in patients undergoing stem cell transplantation or high-dose chemotherapy for hematologic malignancies. The study focuses on understanding the implications of thrombocytopenia, including increased bleeding risks and extended hospital stays due to complications. By gathering baseline blood cell counts, the study seeks to contribute valuable data that may improve management strategies for affected patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years or older with platelet counts of 30,000/mcl or less.
Not a fit: Patients who have undergone chemotherapy within the last 24 hours or are using anticoagulant agents may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better management and treatment strategies for patients with thrombocytopenia, potentially reducing complications and improving outcomes.
How similar studies have performed: While this study focuses on a specific aspect of thrombocytopenia in the context of stem cell transplantation, similar studies have shown success in understanding and managing complications related to low platelet counts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults 18 years or older 2. Platelet counts of 30,000/mcl or less Exclusion Criteria: 1. Chemotherapy within the last 24 hours from the planned blood sample draw for research purposes. 2. Use of anticoagulant agents in the last 48 hours. 3. Active infection (i.e. one that has received less than 48 hours of active treatment). 4. Adults 89 years or older
Where this trial is running
Cleveland, Ohio
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute — Cleveland, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: Paolo Caimi, MD — Case Comprehensive Cancer Center, Cleveland Clinic Taussig Cancer Institute
- Study coordinator: Paolo Caimi, MD
- Email: TaussigResearch@ccf.org
- Phone: 1-866-223-8100
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.